Skip to content

Clinical Observation of Huangqi Simiao Decoction on Spleen stomach Damp heat Syndrome of Type 2 diabetes

Interventional Effect of Huangqi Simiao Decoction on DNA Methylation of Genes Related to Spleen Stomach Damp Heat Syndrome in Type 2 Diabetes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077151
Enrollment
Unknown
Registered
2023-10-31
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Test group:Basic hypoglycemic treatment in internal medicine+Huangqi Simiao decoction
control group:Basic hypoglycemic therapy in internal medicine

Sponsors

Tsinghua University Yuquan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Conform to the diagnostic criteria of type 2 diabetes; ? According to the syndrome differentiation conducted by two experts at or above the level of deputy chief Chinese physician, it is in line with the TCM diagnosis of spleen stomach damp heat syndrome of type 2 diabetes; ? Age 18-70 years old; ? Sign an informed consent form; ? The patient is able to provide detailed contact information and has no short-term migration plan, and is willing to cooperate with follow-up.

Exclusion criteria

Exclusion criteria: ? Those who have a history of critical and serious diseases such as diabetes ketoacidosis, malignant hypertension, myocardial infarction, cerebrovascular accident, heart failure, etc. within six months; ? There are severe infections in the near future (within 4 weeks); ? Patients with severe primary diseases such as heart, liver, brain, kidney, and hematopoietic system, as well as cancer and mental illness; ? Pregnant or preparing pregnant or lactating women; ? Individuals who are known to be allergic to or severely allergic to this type of drug; ? Patients who have participated in other clinical drug trials within the past 3 months; ? Those who have insufficient understanding of this study, are unwilling to participate, or have poor compliance; Non cooperative individuals (those who cannot cooperate with dietary control or do not use medication according to regulations, which affects the determination of efficacy).

Design outcomes

Primary

MeasureTime frame
Traditional Chinese Medicine Syndrome Score;

Secondary

MeasureTime frame
blood glucose;Glycated?Albumin;blood fat;

Countries

CHINA

Contacts

Public ContactFENG Xingzhong

Tsinghua University Yuquan Hospital

fengxz9797@sina.com+86 133 8112 8811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026